XNK broadens its pipeline with bladder cancer study ...Middle East

PR Newswire - News
STOCKHOLM, June 28, 2022 /PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced it is initiating a program targeting urothelial cancer, the most common form of bladder cancer. This is the first project where XNK's proprietary technology platform of natural killer (NK) cell therapies...

Hence then, the article about xnk broadens its pipeline with bladder cancer study was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( XNK broadens its pipeline with bladder cancer study )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News